US Stock MarketDetailed Quotes

RVNC Revance Therapeutics

Watchlist

5.280
+0.080+1.54%

Close Oct 16 16:00 ET

5.276
-0.004-0.08%

Post 16:11 ET

550.07MMarket Cap-1639P/E (TTM)

Revance Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

22.96%-41.13M

5.12%-65.94M

-11.90%-216.58M

-41.58%-42.73M

11.94%-50.96M

-20.71%-53.38M

-13.43%-69.5M

12.63%-193.55M

32.34%-30.18M

-8.85%-57.87M

Net income from continuing operations

44.33%-37.47M

11.11%-53.15M

9.10%-323.99M

61.84%-55.7M

-66.69%-141.18M

-9.58%-67.32M

7.07%-59.79M

-26.70%-356.42M

-131.31%-145.95M

-13.87%-84.69M

Depreciation and amortization

-59.53%1.43M

-70.07%1.98M

-65.02%13.69M

-92.28%1.42M

-75.81%2.13M

-46.57%3.53M

23.10%6.62M

97.18%39.15M

239.14%18.38M

70.54%8.78M

Other non cash items

158.92%1.82M

-11.30%738K

-2.15%3.04M

76.27%832K

-55.07%678K

11.62%701K

66.07%832K

165.81%3.11M

396.84%472K

285.93%1.51M

Change In working capital

-143.93%-10.85M

18.79%-23.14M

-6,698.80%-43.88M

-82.53%3.18M

-1,217.26%-14.12M

-654.61%-4.45M

-65.19%-28.49M

113.93%665K

833.80%18.18M

-121.27%-1.07M

-Change in receivables

-271.32%-6.2M

45.22%-2.21M

-104.48%-16.34M

-674.37%-2.26M

-36.29%-8.37M

-49.24%-1.67M

-259.22%-4.03M

-426.00%-7.99M

123.31%394K

-503.93%-6.14M

-Change in inventory

-17.37%-4.71M

72.34%-2.11M

-148.17%-14.91M

428.09%3.16M

-103.04%-6.42M

-36.36%-4.01M

-1,418.69%-7.64M

-40.44%-6.01M

1,473.68%598K

38.37%-3.16M

-Change in prepaid assets

23.59%-1.38M

109.49%123K

-288.79%-6.79M

15.03%5.23M

-829.41%-8.91M

-816.75%-1.81M

-720.10%-1.3M

305.37%3.6M

165.92%4.54M

-111.35%-959K

-Change in payables and accrued expense

89.84%4.52M

-2.76%-18.72M

-81.47%1.88M

-47.85%8.29M

115.00%9.42M

-55.36%2.38M

-17.51%-18.22M

102.28%10.12M

318.95%15.9M

-34.48%4.38M

-Change in other current assets

-2,503.69%-18.89M

103.11%711K

-386.75%-35.5M

-22.65%2.87M

-398.46%-16.33M

-98.51%786K

66.97%-22.83M

49.27%-7.29M

-59.08%3.71M

265.96%5.47M

-Change in other current liabilities

2,819.75%19.42M

-104.01%-958K

407.87%32.07M

-19.38%-5.58M

277.80%14.45M

98.64%-714K

-66.64%23.91M

-54.18%6.31M

-294.76%-4.67M

-2,055.44%-8.13M

-Change in other working capital

-715.87%-3.61M

-98.08%31K

-322.18%-4.29M

-272.16%-8.53M

-72.67%2.04M

263.23%586K

156.03%1.62M

218.33%1.93M

-93.58%-2.29M

2,794.95%7.47M

Cash from discontinued investing activities

Operating cash flow

22.96%-41.13M

5.12%-65.94M

-11.90%-216.58M

-41.58%-42.73M

11.94%-50.96M

-20.71%-53.38M

-13.43%-69.5M

12.63%-193.55M

32.34%-30.18M

-8.85%-57.87M

Investing cash flow

Cash flow from continuing investing activities

82.57%-6.89M

-133.27%-31.71M

179.06%109.74M

-94.21%2.37M

143.55%51.59M

62.66%-39.53M

113.87%95.32M

-367.88%-138.8M

48.19%40.96M

-804.74%-118.45M

Net PPE purchase and sale

1,024.81%2.99M

-494.71%-5.17M

-114.52%-6.89M

-38.12%-1.78M

-349.40%-4.5M

-50.37%266K

40.25%-870K

69.06%-3.21M

70.44%-1.29M

-140.11%-1M

Net investment purchase and sale

88.39%-4.62M

-127.59%-26.54M

204.94%121.51M

-87.23%5.65M

154.30%59.47M

60.39%-39.8M

92.43%96.19M

-899.03%-115.79M

38.22%44.23M

-597.63%-109.52M

Net other investing changes

----

75.34%-4.88M

24.24%-1.5M

----

-157.14%-19.8M

---1.98M

---7.92M

Cash from discontinued investing activities

Investing cash flow

82.57%-6.89M

-133.27%-31.71M

179.06%109.74M

-94.21%2.37M

143.55%51.59M

62.66%-39.53M

113.87%95.32M

-367.88%-138.8M

48.19%40.96M

-804.74%-118.45M

Financing cash flow

Cash flow from continuing financing activities

-103.50%-3.41M

2,743.12%92.83M

-58.83%136.57M

73.61%-1.63M

-82.28%37.46M

360.53%97.47M

-96.90%3.27M

1,010.50%331.69M

-1,624.20%-6.17M

8,582.70%211.39M

Net issuance payments of debt

39.25%-3.9M

-70.03%-4.23M

-65.35%30.16M

55.03%-2.74M

1,390.15%41.8M

-264.38%-6.41M

-102.53%-2.49M

--87.05M

---6.1M

---3.24M

Net common stock issuance

--0

--97.63M

-59.61%100.18M

--0

339.07%100.18M

--0

1,042.61%248.01M

--0

21,620,100.00%216.2M

Proceeds from stock option exercised by employees

-87.59%557K

-99.79%20K

217.20%15.29M

-42.18%1.26M

-88.67%58K

119.19%4.49M

11,901.27%9.48M

-71.12%4.82M

31.46%2.18M

63.06%512K

Net other financing activities

90.48%-75K

84.16%-591K

-10.64%-9.07M

93.44%-148K

-111.19%-4.4M

59.38%-788K

-94.98%-3.73M

3.89%-8.19M

-79.98%-2.26M

25.74%-2.08M

Cash from discontinued financing activities

Financing cash flow

-103.50%-3.41M

2,743.12%92.83M

-58.83%136.57M

73.61%-1.63M

-82.28%37.46M

360.53%97.47M

-96.90%3.27M

1,010.50%331.69M

-1,624.20%-6.17M

8,582.70%211.39M

Net cash flow

Beginning cash position

-2.89%139.93M

25.85%144.75M

-0.56%115.02M

69.13%186.74M

97.31%148.66M

-29.46%144.1M

-0.56%115.02M

-65.68%115.67M

-16.50%110.41M

-55.96%75.34M

Current changes in cash

-1,228.62%-51.43M

-116.57%-4.82M

4,660.12%29.73M

-1,011.83%-41.99M

8.58%38.08M

103.53%4.56M

-67.18%29.08M

99.71%-652K

127.80%4.61M

190.27%35.07M

End cash Position

-40.47%88.5M

-2.89%139.93M

25.85%144.75M

69.13%186.74M

97.31%148.66M

-29.46%144.1M

-0.56%115.02M

-16.50%110.41M

Free cash flow

28.20%-38.14M

-1.06%-71.11M

-13.57%-223.46M

-41.44%-44.51M

5.79%-55.47M

-21.58%-53.12M

-12.19%-70.37M

15.16%-196.76M

35.73%-31.47M

-16.19%-58.87M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	22.96%-41.13M	5.12%-65.94M	-11.90%-216.58M	-41.58%-42.73M	11.94%-50.96M	-20.71%-53.38M	-13.43%-69.5M	12.63%-193.55M	32.34%-30.18M	-8.85%-57.87M
Net income from continuing operations	44.33%-37.47M	11.11%-53.15M	9.10%-323.99M	61.84%-55.7M	-66.69%-141.18M	-9.58%-67.32M	7.07%-59.79M	-26.70%-356.42M	-131.31%-145.95M	-13.87%-84.69M
Depreciation and amortization	-59.53%1.43M	-70.07%1.98M	-65.02%13.69M	-92.28%1.42M	-75.81%2.13M	-46.57%3.53M	23.10%6.62M	97.18%39.15M	239.14%18.38M	70.54%8.78M
Other non cash items	158.92%1.82M	-11.30%738K	-2.15%3.04M	76.27%832K	-55.07%678K	11.62%701K	66.07%832K	165.81%3.11M	396.84%472K	285.93%1.51M
Change In working capital	-143.93%-10.85M	18.79%-23.14M	-6,698.80%-43.88M	-82.53%3.18M	-1,217.26%-14.12M	-654.61%-4.45M	-65.19%-28.49M	113.93%665K	833.80%18.18M	-121.27%-1.07M
-Change in receivables	-271.32%-6.2M	45.22%-2.21M	-104.48%-16.34M	-674.37%-2.26M	-36.29%-8.37M	-49.24%-1.67M	-259.22%-4.03M	-426.00%-7.99M	123.31%394K	-503.93%-6.14M
-Change in inventory	-17.37%-4.71M	72.34%-2.11M	-148.17%-14.91M	428.09%3.16M	-103.04%-6.42M	-36.36%-4.01M	-1,418.69%-7.64M	-40.44%-6.01M	1,473.68%598K	38.37%-3.16M
-Change in prepaid assets	23.59%-1.38M	109.49%123K	-288.79%-6.79M	15.03%5.23M	-829.41%-8.91M	-816.75%-1.81M	-720.10%-1.3M	305.37%3.6M	165.92%4.54M	-111.35%-959K
-Change in payables and accrued expense	89.84%4.52M	-2.76%-18.72M	-81.47%1.88M	-47.85%8.29M	115.00%9.42M	-55.36%2.38M	-17.51%-18.22M	102.28%10.12M	318.95%15.9M	-34.48%4.38M
-Change in other current assets	-2,503.69%-18.89M	103.11%711K	-386.75%-35.5M	-22.65%2.87M	-398.46%-16.33M	-98.51%786K	66.97%-22.83M	49.27%-7.29M	-59.08%3.71M	265.96%5.47M
-Change in other current liabilities	2,819.75%19.42M	-104.01%-958K	407.87%32.07M	-19.38%-5.58M	277.80%14.45M	98.64%-714K	-66.64%23.91M	-54.18%6.31M	-294.76%-4.67M	-2,055.44%-8.13M
-Change in other working capital	-715.87%-3.61M	-98.08%31K	-322.18%-4.29M	-272.16%-8.53M	-72.67%2.04M	263.23%586K	156.03%1.62M	218.33%1.93M	-93.58%-2.29M	2,794.95%7.47M
Cash from discontinued investing activities
Operating cash flow	22.96%-41.13M	5.12%-65.94M	-11.90%-216.58M	-41.58%-42.73M	11.94%-50.96M	-20.71%-53.38M	-13.43%-69.5M	12.63%-193.55M	32.34%-30.18M	-8.85%-57.87M
Investing cash flow
Cash flow from continuing investing activities	82.57%-6.89M	-133.27%-31.71M	179.06%109.74M	-94.21%2.37M	143.55%51.59M	62.66%-39.53M	113.87%95.32M	-367.88%-138.8M	48.19%40.96M	-804.74%-118.45M
Net PPE purchase and sale	1,024.81%2.99M	-494.71%-5.17M	-114.52%-6.89M	-38.12%-1.78M	-349.40%-4.5M	-50.37%266K	40.25%-870K	69.06%-3.21M	70.44%-1.29M	-140.11%-1M
Net investment purchase and sale	88.39%-4.62M	-127.59%-26.54M	204.94%121.51M	-87.23%5.65M	154.30%59.47M	60.39%-39.8M	92.43%96.19M	-899.03%-115.79M	38.22%44.23M	-597.63%-109.52M
Net other investing changes	----	----	75.34%-4.88M	24.24%-1.5M	----	----	----	-157.14%-19.8M	---1.98M	---7.92M
Cash from discontinued investing activities
Investing cash flow	82.57%-6.89M	-133.27%-31.71M	179.06%109.74M	-94.21%2.37M	143.55%51.59M	62.66%-39.53M	113.87%95.32M	-367.88%-138.8M	48.19%40.96M	-804.74%-118.45M
Financing cash flow
Cash flow from continuing financing activities	-103.50%-3.41M	2,743.12%92.83M	-58.83%136.57M	73.61%-1.63M	-82.28%37.46M	360.53%97.47M	-96.90%3.27M	1,010.50%331.69M	-1,624.20%-6.17M	8,582.70%211.39M
Net issuance payments of debt	39.25%-3.9M	-70.03%-4.23M	-65.35%30.16M	55.03%-2.74M	1,390.15%41.8M	-264.38%-6.41M	-102.53%-2.49M	--87.05M	---6.1M	---3.24M
Net common stock issuance	--0	--97.63M	-59.61%100.18M	--0	--0	339.07%100.18M	--0	1,042.61%248.01M	--0	21,620,100.00%216.2M
Proceeds from stock option exercised by employees	-87.59%557K	-99.79%20K	217.20%15.29M	-42.18%1.26M	-88.67%58K	119.19%4.49M	11,901.27%9.48M	-71.12%4.82M	31.46%2.18M	63.06%512K
Net other financing activities	90.48%-75K	84.16%-591K	-10.64%-9.07M	93.44%-148K	-111.19%-4.4M	59.38%-788K	-94.98%-3.73M	3.89%-8.19M	-79.98%-2.26M	25.74%-2.08M
Cash from discontinued financing activities
Financing cash flow	-103.50%-3.41M	2,743.12%92.83M	-58.83%136.57M	73.61%-1.63M	-82.28%37.46M	360.53%97.47M	-96.90%3.27M	1,010.50%331.69M	-1,624.20%-6.17M	8,582.70%211.39M
Net cash flow
Beginning cash position	-2.89%139.93M	25.85%144.75M	-0.56%115.02M	69.13%186.74M	97.31%148.66M	-29.46%144.1M	-0.56%115.02M	-65.68%115.67M	-16.50%110.41M	-55.96%75.34M
Current changes in cash	-1,228.62%-51.43M	-116.57%-4.82M	4,660.12%29.73M	-1,011.83%-41.99M	8.58%38.08M	103.53%4.56M	-67.18%29.08M	99.71%-652K	127.80%4.61M	190.27%35.07M
End cash Position	-40.47%88.5M	-2.89%139.93M	25.85%144.75M	25.85%144.75M	69.13%186.74M	97.31%148.66M	-29.46%144.1M	-0.56%115.02M	-0.56%115.02M	-16.50%110.41M
Free cash flow	28.20%-38.14M	-1.06%-71.11M	-13.57%-223.46M	-41.44%-44.51M	5.79%-55.47M	-21.58%-53.12M	-12.19%-70.37M	15.16%-196.76M	35.73%-31.47M	-16.19%-58.87M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data